Identification of the erythrocyte receptor for Plasmodium yoelii RhopH complex

约氏疟原虫 RhopH 复合物红细胞受体的鉴定

基本信息

  • 批准号:
    16017272
  • 负责人:
  • 金额:
    $ 9.6万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas
  • 财政年份:
    2004
  • 资助国家:
    日本
  • 起止时间:
    2004 至 2005
  • 项目状态:
    已结题

项目摘要

Parasitophorous vacuole formation is a critical step for the successful invasion of host erythrocytes by malaria parasite. Rhoptry proteins are believed to have essential roles in vacuole formation, although their biological roles are poorly understood. To understand the molecular interactions between parasite rhoptry proteins and the erythrocyte during invasion, we have characterized the binding specificity of the high molecular mass rhoptry protein (RhopH) complex to erythrocytes using the rodent malaria parasite, Plasmodium yoelii and proposed that the major erythrocyte receptor for PyRhopH complex is a protein attached to the erythrocyte surface via GPI-anchor.To further characterize and identify the unknown receptor protein, we employed forward genetic analysis using consomic mouse strains derived from C57BL/6J (B6) and MSM/Ms strains based on the difference in the PyRhopH complex binding to the erythrocytes from these mice (erythrocytes from B6 exhibited higher binding than MSM/Ms). These consomic strains have B6 genetic background and a particular chromosome or chromosomal region is replaced with the one from MSM/Ms. A panel of consomic strains available were examined and the binding among consomic strains were found to be not clearly differentiate to B6 type or MSM/Ms type, indicating that multiple factors were involved in the observed binding. However B6-11^<MSM/Ms>, which harbored chromosome 11 derived from MSM/Ms, showed a prominent low binding, even lower than MSM/Ms, thus we considered that the receptor protein potentially located on chromosome 11. Based on this assumption, we are in a process to narrow the candidate region on the chromosome 11 by further linkage analysis between B6 and B6-11^<MSM/Ms>. The GPI-anchored protein on the candidate region would be characterized as a prime candidate for the PyRhopH complex receptor.
寄生虫形成是成功入侵疟疾寄生虫宿主红细胞的关键步骤。据信,罗普特蛋白在液泡形成中具有重要作用,尽管它们的生物学作用知之甚少。为了了解寄生虫rhoptry蛋白与入侵期间寄生虫之间的分子相互作用,我们表征了使用啮齿动物疟原虫寄生虫,质子质量YOELII的高分子质量综合蛋白(Rhhoph)复合物与红细胞与红细胞的结合特异性,该蛋白酶与主要的互联网相关的IS IS IS IS IS IS IS IS IS IS IS IS IS IS IS IS IS IS IS IS IS IS IS IS IS IS IS IS IS IS IS IS IS IS IS IS IS IS IS IS IS IS IS IS IS IS IS IS IS IS的肌料置于侵蚀薄片的复合物。通过GPI锚固的表面为了进一步表征和识别未知的受体蛋白,我们使用源自C57BL/6J(B6)和MSM/MS菌株的综合小鼠菌株基于pyRhoph复合物的差异与这些小鼠(Erythrocytiped by MSM MSM的erythocytes comploy)的伴侣菌株和MSM/MS菌株。这些综合菌株具有B6遗传背景,并且特定的染色体或染色体区域被MSM/MS的染色体区域取代。检查了一系列可用的综合菌株,并发现合成菌株之间的结合并未明显与B6型或MSM/MS类型区分开,这表明观察到的结合中涉及多个因素。 However B6-11^<MSM/Ms>, which harbored chromosome 11 derived from MSM/Ms, showed a prominent low binding, even lower than MSM/Ms, thus we considered that the receptor protein potentially located on chromosome 11. Based on this assumption, we are in a process to narrow the candidate region on the chromosome 11 by further linkage analysis between B6 and B6-11^<MSM/Ms>.候选区域的GPI锚定蛋白将被描述为pyRhoph复合物受体的主要候选者。

项目成果

期刊论文数量(18)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Potent immunogenicity of DNA vaccines encoding Plasmodium vivax transmission-blocking vaccine candidates Pvs25 and Pvs28-evaluation of
编码间日疟原虫传播阻断候选疫苗 Pvs25 和 Pvs28 的 DNA 疫苗的有效免疫原性-评估
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Kaneko 0;Yim-Lim BYS;Iriko H;Ling IT;Otsuki H;Grainger M;Tsuboi T;Adams JH;Mattei D;Holder AA;Torii M.;Kaneko O et al.;Winter G et al.;Kongkasuriyachai D et al.
  • 通讯作者:
    Kongkasuriyachai D et al.
Apical expression of three RhopHl/Clag proteins as components of the Plasmodium falcioarum RhopH complex.
作为镰状疟原虫 RhopH 复合物成分的三种 RhopH1/Clag 蛋白的顶端表达。
  • DOI:
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Kaneko 0;Yim-Lim BYS;Iriko H;Ling IT;Otsuki H;Grainger M;Tsuboi T;Adams JH;Mattei D;Holder AA;Torii M.
  • 通讯作者:
    Torii M.
2-Cys peroxiredoxin TPx-1 is involved in gametocyte development in Plasmodium berghei
  • DOI:
    10.1016/j.molbiopara.2006.02.018
  • 发表时间:
    2006-07-01
  • 期刊:
  • 影响因子:
    1.5
  • 作者:
    Yano, Kazuhiko;Komaki-Yasuda, Kanako;Kawazu, Shin-ichiro
  • 通讯作者:
    Kawazu, Shin-ichiro
Nasal immunization with a malaria transmission-blocking vaccine candidate Pfs25 induces complete protective immunity in mice against field-isolated Plasmodium falciparum
使用阻断疟疾传播的候选疫苗 Pfs25 进行鼻免疫可诱导小鼠针对现场隔离的恶性疟原虫产生完全保护性免疫力
Apical expression of three RhopH1/Clag proteins as components of th Plasmodium falciparum RhopH complex
作为恶性疟原虫 RhopH 复合物成分的三种 RhopH1/Clag 蛋白的顶端表达
  • DOI:
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Kaneko 0;Yim-Lim BYS;Iriko H;Ling IT;Otsuki H;Grainger M;Tsuboi T;Adams JH;Mattei D;Holder AA;Torii M.;Kaneko O et al.
  • 通讯作者:
    Kaneko O et al.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TORII Motomi其他文献

TORII Motomi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TORII Motomi', 18)}}的其他基金

Development of novel transmission blocking vaccine targeting microgamete surface antigen of Plasmodium falciparum
针对恶性疟原虫小配子表面抗原的新型传播阻断疫苗的开发
  • 批准号:
    20H03480
  • 财政年份:
    2020
  • 资助金额:
    $ 9.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Assessment of P. vivax transmission-blocking activity of novel vaccine candidate (PvGs24)
新型候选疫苗 (PvGs24) 间日疟原虫传播阻断活性的评估
  • 批准号:
    16H05816
  • 财政年份:
    2016
  • 资助金额:
    $ 9.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of novel P. falciparum malaria transmission-blocking vaccine targeted against Pf75
开发针对 Pf75 的新型恶性疟原虫疟疾传播阻断疫苗
  • 批准号:
    15H04725
  • 财政年份:
    2015
  • 资助金额:
    $ 9.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of novel malaria transmission blocking vaccine
新型疟疾传播阻断疫苗的开发
  • 批准号:
    21406010
  • 财政年份:
    2009
  • 资助金额:
    $ 9.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Screening of sporozoite receptor molecule(s) on hepatocytes
肝细胞上子孢子受体分子的筛选
  • 批准号:
    21390124
  • 财政年份:
    2009
  • 资助金额:
    $ 9.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Identification of erythrocyte proteins interacting with RhopH complex of malaria parasites
鉴定与疟原虫 RhopH 复合物相互作用的红细胞蛋白
  • 批准号:
    19390120
  • 财政年份:
    2007
  • 资助金额:
    $ 9.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Rosetting of infected erythrocyte and virulence of Vivax malaria
受感染红细胞的玫瑰花结和间日疟疾的毒力
  • 批准号:
    18406009
  • 财政年份:
    2006
  • 资助金额:
    $ 9.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Identification of the binding domain of Plasmodium falciparum erythrocyte binding protein.
恶性疟原虫红细胞结合蛋白结合域的鉴定。
  • 批准号:
    16390126
  • 财政年份:
    2004
  • 资助金额:
    $ 9.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Analysis of the protein expression level of the erythrocyte binding proteins in Plasmodium falciparum field isolates.
恶性疟原虫野外分离株中红细胞结合蛋白的蛋白表达水平分析。
  • 批准号:
    15406015
  • 财政年份:
    2003
  • 资助金额:
    $ 9.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Structure and functional analysis of high molecule weight rhoptry protein complex, RhopH, of rodent malaria parasite.
啮齿动物疟原虫高分子量棒状体蛋白复合物 RhopH 的结构和功能分析。
  • 批准号:
    14370084
  • 财政年份:
    2002
  • 资助金额:
    $ 9.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)

相似国自然基金

PfAP2-R介导的PfCRT转录调控在恶性疟原虫对喹啉类药物抗性中的作用及机制研究
  • 批准号:
    82372275
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
恶性疟原虫顶质体磷酸丙糖转运蛋白的转运机制研究与抑制剂筛选
  • 批准号:
    32371272
  • 批准年份:
    2023
  • 资助金额:
    50.00 万元
  • 项目类别:
    面上项目
免疫受体TLR2在疟原虫增强蚊虫吸引力促进疟疾传播中的作用和机制
  • 批准号:
    82302570
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
甘露糖抑制红内期疟原虫生长和脑型疟疾发生的机制研究
  • 批准号:
    32200976
  • 批准年份:
    2022
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目
甘露糖抑制红内期疟原虫生长和脑型疟疾发生的机制研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Parasite and host cell factors involved in the formation and persistence of Plasmodium vivax hypnozoites
寄生虫和宿主细胞因子参与间日疟原虫休眠子的形成和持续存在
  • 批准号:
    10564073
  • 财政年份:
    2023
  • 资助金额:
    $ 9.6万
  • 项目类别:
Multiplex analysis of IgA and IgG antibody responses to early childhood malaria infections to inform vaccine development
对儿童早期疟疾感染的 IgA 和 IgG 抗体反应进行多重分析,为疫苗开发提供信息
  • 批准号:
    10647960
  • 财政年份:
    2023
  • 资助金额:
    $ 9.6万
  • 项目类别:
Synthesizing immunoinformatics and genetic epidemiology to identify signatures of natural functional immunity to malaria parasites
综合免疫信息学和遗传流行病学,以确定对疟疾寄生虫的天然功能免疫特征
  • 批准号:
    10642330
  • 财政年份:
    2023
  • 资助金额:
    $ 9.6万
  • 项目类别:
After the flood: Optimal strategies to prevent malaria epidemics caused by severe flooding
洪水过后:预防严重洪水引起的疟疾流行的最佳策略
  • 批准号:
    10803934
  • 财政年份:
    2023
  • 资助金额:
    $ 9.6万
  • 项目类别:
Synthetic studies and antimalarial activities of bastimolides and related polyketides
巴斯蒂莫内酯及相关聚酮化合物的合成研究和抗疟活性
  • 批准号:
    10667027
  • 财政年份:
    2023
  • 资助金额:
    $ 9.6万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了